UBS ends price stabilisation for Foundation Healthcare IPO

SGX Filings
08/08

UBS AG, Singapore Branch announced it has completed price stabilisation measures for the initial public offering of Foundation Healthcare Holdings Limited.

The stabilising manager disclosed that, up to Aug, 07 2026, it had bought a total of 21.25 million shares in Foundation Healthcare Holdings Limited and has now ceased all stabilising actions.

UBS added that the over-allotment option granted by SeaTown Private Capital Master Fund to the joint bookrunners and underwriters—Jefferies Singapore Limited, Oversea-Chinese Banking Corporation Limited, UBS AG Singapore Branch, DBS Bank Ltd. and United Overseas Bank Limited—was partially exercised for 3.03 million shares to cover the remaining balance of the 24.28 million shares previously over-allotted in connection with the offering.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10